TY - JOUR
T1 - SoxF Transcription Factors Are Positive Feedback Regulators of VEGF Signaling
AU - Kim, Kangsan
AU - Kim, Il Kug
AU - Yang, Jee Myung
AU - Lee, Eunhyeong
AU - Koh, Bong Ihn
AU - Song, Sukhyun
AU - Park, Junseong
AU - Lee, Sungsu
AU - Choi, Chulhee
AU - Kim, Jin Woo
AU - Kubota, Yoshiaki
AU - Koh, Gou Young
AU - Kim, Injune
N1 - Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2016/9/16
Y1 - 2016/9/16
N2 - Rationale: Vascular endothelial growth factor (VEGF) signaling is a key pathway for angiogenesis and requires highly coordinated regulation. Although the Notch pathway-mediated suppression of excessive VEGF activity via negative feedback is well known, the positive feedback control for augmenting VEGF signaling remains poorly understood. Transcription factor Sox17 is indispensable for angiogenesis, but its association with VEGF signaling is largely unknown. The contribution of other Sox members to angiogenesis also remains to be determined. Objective: To reveal the genetic interaction of Sox7, another Sox member, with Sox17 in developmental angiogenesis and their functional relationship with VEGF signaling. Methods and Results: Sox7 is expressed specifically in endothelial cells and its global and endothelial-specific deletion resulted in embryonic lethality with severely impaired angiogenesis in mice, substantially overlapping with Sox17 in both expression and function. Interestingly, compound heterozygosity for Sox7 and Sox17 phenocopied vascular defects of Sox7 or Sox17 homozygous knockout, indicating that the genetic cooperation of Sox7 and Sox17 is sensitive to their combined gene dosage. VEGF signaling upregulated both Sox7 and Sox17 expression in angiogenesis via mTOR pathway. Furthermore, Sox7 and Sox17 promoted VEGFR2 (VEGF receptor 2) expression in angiogenic vessels, suggesting a positive feedback loop between VEGF signaling and SoxF. Conclusions: Our findings demonstrate that SoxF transcription factors are indispensable players in developmental angiogenesis by acting as positive feedback regulators of VEGF signaling.
AB - Rationale: Vascular endothelial growth factor (VEGF) signaling is a key pathway for angiogenesis and requires highly coordinated regulation. Although the Notch pathway-mediated suppression of excessive VEGF activity via negative feedback is well known, the positive feedback control for augmenting VEGF signaling remains poorly understood. Transcription factor Sox17 is indispensable for angiogenesis, but its association with VEGF signaling is largely unknown. The contribution of other Sox members to angiogenesis also remains to be determined. Objective: To reveal the genetic interaction of Sox7, another Sox member, with Sox17 in developmental angiogenesis and their functional relationship with VEGF signaling. Methods and Results: Sox7 is expressed specifically in endothelial cells and its global and endothelial-specific deletion resulted in embryonic lethality with severely impaired angiogenesis in mice, substantially overlapping with Sox17 in both expression and function. Interestingly, compound heterozygosity for Sox7 and Sox17 phenocopied vascular defects of Sox7 or Sox17 homozygous knockout, indicating that the genetic cooperation of Sox7 and Sox17 is sensitive to their combined gene dosage. VEGF signaling upregulated both Sox7 and Sox17 expression in angiogenesis via mTOR pathway. Furthermore, Sox7 and Sox17 promoted VEGFR2 (VEGF receptor 2) expression in angiogenic vessels, suggesting a positive feedback loop between VEGF signaling and SoxF. Conclusions: Our findings demonstrate that SoxF transcription factors are indispensable players in developmental angiogenesis by acting as positive feedback regulators of VEGF signaling.
KW - SoxF transcription factors
KW - endothelial cells
KW - physiologic angiogenesis
KW - physiological feedback
KW - vascular endothelial growth factor A
UR - http://www.scopus.com/inward/record.url?scp=84984682158&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84984682158&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.116.308483
DO - 10.1161/CIRCRESAHA.116.308483
M3 - Article
C2 - 27528602
AN - SCOPUS:84984682158
SN - 0009-7330
VL - 119
SP - 839
EP - 852
JO - Circulation Research
JF - Circulation Research
IS - 7
ER -